EGFR and neoplasm: In a preclinical study, taking tumor bearing mice treated with anti-EGFR-guided LIGHT fusion protein into account, the study illustrated that the activation of lymphotoxin β-receptor induced production of chemokines which led to extensive T cell recruitment.